P1629: ADMINISTRATION OF CONVALESCENT PLASMA FOR THE TREATMENT OF SEVERE COVID-19: RESULTS OF A MULTICENTER PHASE II TRIAL. (23rd June 2022)

Record Type:
Journal Article
Title:
P1629: ADMINISTRATION OF CONVALESCENT PLASMA FOR THE TREATMENT OF SEVERE COVID-19: RESULTS OF A MULTICENTER PHASE II TRIAL. (23rd June 2022)
Main Title:
P1629: ADMINISTRATION OF CONVALESCENT PLASMA FOR THE TREATMENT OF SEVERE COVID-19: RESULTS OF A MULTICENTER PHASE II TRIAL
Authors:
Thomopoulos, T.
Bouchla, A.
Antoniadou, A.
Terpos, E.
Politou, M.
Stamoulis, K.
Koromboki, E.
Papageorgiou, S.
Kotanidou, A.
Kalomenidis, I.
Jahaj, E.
Grigoropoulou, S.
Pagoni, M.
Grouzi, E.
Poulakou, G.
Trontzas, I.
Labropoulou, S.
Mentis, A.
Bamias, A.
Tsiodras, S.
Dimopoulos, M.-A.
Pappa, V.
Abstract:
Is Part Of:
HemaSphere. Volume 6(2022)Supplement 3
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Issue Display:
Volume 6, Issue 3 (2022)
Year:
2022
Volume:
6
Issue:
3
Issue Sort Value:
2022-0006-0003-0000
Page Start:
1510
Page End:
1511
Publication Date:
2022-06-23
Subjects:
Hematology -- Periodicals
616.15005
Journal URLs:
https://journals.lww.com/hemasphere/pages/default.aspx ↗
http://journals.lww.com/pages/default.aspx ↗
DOI:
10.1097/01.HS9.0000849372.14120.8e ↗
Languages:
English
ISSNs:
2572-9241
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:
22732.xml